Background: Myocyte contractile dysfunction occurs in pathological remodeling in association with abnormalities in calcium regulation. Mice with cardiac myocyte-specific overexpression of G␣q develop progressive left ventricular failure associated with myocyte contractile dysfunction and calcium dysregulation. Objective:We tested the hypothesis that myocyte contractile dysfunction in the G␣q mouse heart is mediated by reactive oxygen species, and in particular, oxidative posttranslational modifications, which impair the function of sarcoplasmic reticulum Ca
M yocyte contractile dysfunction occurs in several models of pathological remodeling including pressure overload [1] [2] [3] [4] and after myocardial infarction. [5] [6] [7] [8] Although myocyte dysfunction appears to be caused, at least in part, by abnormalities in calcium regulation, 9 the underlying mechanism remains unclear. There is evidence that reactive oxygen species (ROS) mediate some aspects of pathological myocardial remodeling including myocyte hypertrophy and apoptosis. 10 -12 Mice with cardiac myocyte-specific overexpression of G␣q develop progressive left ventricular (LV) dilation and failure 13 associated with myocyte contractile dysfunction and calcium dysregulation. 14 These mice have increased oxidative stress in the myocardium, 15 and recently, we demonstrated that concomitant myocytespecific expression of catalase ameliorated pathological LV remodeling, inhibited myocyte hypertrophy and apoptosis, and preserved LV contractile function. 16 Accordingly, we tested the hypothesis that myocyte contractile dysfunction in the G␣q mouse heart is also mediated by ROS, and in particular, involves oxidative posttranslational modifications (OPTM) that impair the function of sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA). 17 
Methods
Briefly, transgenic mice with cardiac myocyte-specific overexpression of G␣q (G␣q-40 mice, FVB/N) 13 and wild-type (FVB/N) mice were crossbred with transgenic mice having myocyte-specific overexpression of catalase, 18 as we previously described. 16 Myocytes were isolated, and contraction and intracellular calcium transients were measured, as we have described previously. 19 SERCA2 activity was measured using calcium-stimulated, thapsigargin-inhibitable calcium uptake in an SR membrane preparation by a modification of published methods, 14 ,20 as we have described. 21 BIAM-labeling, immunoblotting, and immunohistochemical detection of SERCA OPTM are available in the Online Data Supplement. All data are presented as meansϮSEM.
Results

Concurrent Myocyte-Specific Catalase Overexpression Ameliorates Contractile Dysfunction and Calcium Dysregulation in Myocytes From G␣q Mice
Ventricular myocytes were isolated from mice with myocytespecific overexpression of G␣q, [13] [14] [15] [16] and myocyte contractile function and intracellular calcium transients were assessed, as we have described. 19, 21 In myocytes from G␣q mice (versus wild type), the amplitude of cell shortening was decreased by 53%, and the rates of myocyte shortening and relaxation were reduced by 62% and 63%, respectively ( Figure 1A through  1C) . Likewise, in G␣q myocytes, the calcium transient amplitude was decreased by 37%, and the rates of rise and decline were decreased by 34% and 33%, respectively (Figure 1D through 1F ). G␣q mice were crossbred with mice that have myocyte-specific overexpression of catalase, 18 as we have described. 16 In myocytes from G␣q/catalase mice, the amplitude of cell shortening and the rates of cell shortening and relaxation were improved ( Figure 1A through 1C) and the abnormalities in calcium transient amplitude and kinetics were ameliorated ( Figure 1D through 1F).
Expression of Calcium Regulating Proteins in G␣q Myocardium
The protein levels of SERCA, the ryanodine receptor (RyR), phospholamban (PLB), and the sodium/calcium exchanger (NCX) were determined by immunoblotting. RyR protein expression was decreased by 47% in G␣q mice, whereas the expression of SERCA, PLB, and NCX was unchanged (Table) . The decrease in RyR protein was associated with a 42% decrease in mRNA (Online Figure I) , suggesting that the Concurrent expression of catalase in G␣q/catalase mice had no effect on RyR protein or transcript levels (Table and Online Figure I ).
OPTM of SERCA in G␣q Myocardium
To test whether OPTM may contribute to contractile dysfunction in G␣q myocytes, oxidative thiol modifications of SERCA and RyR were assessed using biotinylated iodoacetamide (BIAM), as we have described. 17, 22 Compared with wild type, the fraction of BIAM-labeled SERCA in Gaq was decreased by 36% ( Figure 2A and 2B), whereas BIAMlabeling of RyR was unchanged (data not shown). We have developed antibodies directed at SERCA that are sulfonylated at cysteine 674 23 or nitrated at tyrosine 294/295. 24 Using these antibodies, immunohistochemistry revealed increased staining for both OPTM diffusely over myocytes in G␣q hearts ( Figure 2C and 2D). In myocardium from G␣q/catalase mice (compared with G␣q mice), there was (1) increased BIAM labeling of SERCA ( 
Decreased SERCA Activity in G␣q Myocardium Is Restored by Catalase
To assess the functional consequence of the observed OPTM, SERCA activity was measured using maximal calciumstimulated calcium uptake in sarcolemmal membranes, as we have described. 21 SERCA-mediated calcium uptake was reduced by 47% in G␣q membranes ( Figure 3 ). In myocytes from G␣q/catalase mice, maximal calcium-stimulated SERCA activity was restored to wild-type levels ( Figure 3 ). Decreased SERCA activity in G␣q myocardium is corrected by concurrent expression of catalase in G␣q/ catalase mice. Maximum SERCA activity was assessed using maximum calcium-stimulated, thapsigargin-inhibited calcium uptake. 21 Shown are mean data for 7 to 8 hearts in each group (*PϽ0.05 vs wild type [WT]; †PϽ0.05 vs G␣q).
Discussion
We used the G␣q mouse model of dilated cardiomyopathy to examine the role of protein OPTM in mediating myocyte contractile dysfunction. Prior work from Satoh et al 15 and our group 16 demonstrated increased oxidative stress in the myocardium of these mice. Likewise, our finding of contractile dysfunction and abnormal calcium regulation in G␣q myocytes confirms and extends the prior report by Yatani et al. 14 Recently, we demonstrated that concurrent cardiac myocytespecific overexpression of catalase improved cardiac function in these mice. 16 Accordingly, we hypothesized that catalase would improve myocyte function and thereby allow the identification of catalase-sensitive OPTM of myocyte proteins involved in the pathophysiology of contractile dysfunction.
Our initial finding was that cardiac myocyte-specific overexpression of catalase ameliorated the abnormalities in cardiac myocyte contractile function and calcium regulation. This indicates that a catalase-sensitive pathway is involved in mediating myocyte dysfunction and directed our attention to proteins involved in calcium handling. Of the proteins primarily involved in myocyte calcium regulation, only the expression of RyR was decreased. However, the decreases in RyR protein and its mRNA were not affected by catalase and thus are not responsible for the effect of catalase on myocyte function that we observed.
SERCA activity was decreased in G␣q myocardium, consistent with prior observations in this 14 and other models of heart failure. 9, 25 However, the expression of SERCA was not decreased, which is also consistent with prior observations in this mouse. 13 Of note, SERCA activity was corrected by concurrent catalase expression, suggesting that OPTM of SERCA might be responsible for decreased SERCA activity. This thesis was further supported by 3 observations. First, in G␣q myocardium, there was a decrease in the quantity of BIAM binding to SERCA, which indicates oxidative modification of the most reactive SERCA cysteine, cysteine 674, and potentially other cysteines. 17 Importantly, the quantity of BIAM binding to SERCA was restored toward normal in G␣q/catalase mice, confirming that the modification was oxidative in nature. Second, there was immunohistochemical evidence of sulfonylation of SERCA at cysteine 674. 23 This OPTM is noteworthy because we have shown that sulfonylation of SERCA cysteine 674 in atherosclerotic aortic smooth muscle is associated with decreased activity. 23 Third, there was immunohistochemical evidence of nitration of SERCA tyrosine 294/295. 24 Sulfonylation of SERCA at cysteine 674 and nitration of tyrosine at 294/295 provide evidence of irreversible oxidation by elevated oxidants. 23 As with BIAM binding, both SERCA sulfonylation and nitration were markedly decreased in G␣q/catalase mice. These findings thus directly identify 2 specific OPTM of SERCA in the G␣q mouse and demonstrate that both can be prevented by catalase. This observation implicates H 2 O 2 in the oxidation of SERCA cysteine 674 26 and the nitration of SERCA tyrosines. 27 H 2 O 2 probably is derived through dismutation of superoxide that is produced by mitochondria and/or oxidases.
Although we have identified 2 specific irreversible OPTM that are associated with decreased SERCA activity, we cannot exclude phosphorylation of calcium-regulating proteins caused by oxidative regulation of a phosphatase. However, we think it is unlikely that this mechanism could explain our primary observation (correction of maximal calciumstimulated SERCA activity) because (1) SERCA is not known to have regulatory phosphorylation sites; and (2) SERCA activity was measured using maximal calcium stimulation, which is not sensitive to PLB. On the other hand, oxidative regulation of phosphorylation might contribute to other aspects of contractile dysfunction in this model.
Prior studies in mice have implicated abnormal calcium handling, and in particular, decreased SERCA function in the pathophysiology of myocyte contractile dysfunction. 3, 4, 28, 29 Likewise, numerous studies have identified decreased SERCA activity in failing human myocardium, 30 -32 which, in some cases, has been associated with normal SERCA protein levels. 31, 32 In preliminary studies, we have found immunohistochemical evidence that SERCA is sulfonylated at cysteine 674 in myocardium from patients with heart failure caused by dilated cardiomyopathy but not in myocardium from patients without heart failure (unpublished data), thus suggesting that our findings in the G␣q mouse are relevant to human disease.
Novel findings of this study include the demonstration of (1) multiple specific oxidative modifications of SERCA; (2) the relationship between SERCA OPTM and reduced SERCA activity and altered cellular calcium handling; and (3) the rescue of OPTM, SERCA activity, and cellular calcium handling by myocyte-specific overexpression of catalase. Taken together, our data suggest that cardiac myocyte contractile dysfunction in the G␣q mouse is mediated, in part, by catalase-sensitive OPTM of SERCA. These observations suggest that OPTM caused by H 2 O 2 contribute to myocardial dysfunction in pathological states, such as heart failure, that are associated with increased oxidant levels in the heart.
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Novelty and Significance
What Is Known?
• Myocyte dysfunction and calcium dysregulation occur in human heart failure in association with increased reactive oxygen species in the myocardium.
• Mice with myocyte-specific overexpression of G␣q develop a dilated cardiomyopathy that progresses to heart failure associated with myocyte contractile dysfunction and calcium dysregulation.
• ROS are increased in the G␣q-overexpressing mouse heart.
What New Information Does This Article Contribute?
• G␣q-overexpressing mice exhibit specific irreversible oxidative posttranslational modifications (OPTM) of sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA) consisting of sulfonylation at cysteine 674 and nitration at tyrosine 294/295.
• OPTM of SERCA in G␣q-overexpressing mice are associated with reduced SERCA activity in myocardium, myocyte calcium dysregulation, and myocyte contractile dysfunction.
• Myocyte-specific overexpression of catalase prevents OPTM of SERCA, restores SERCA activity, and improves myocyte calcium dysregulation and contractile dysfunction.
We tested whether myocyte dysfunction in G␣q mice is mediated by OPTM of SERCA. In G␣q myocardium there were specific OPTM of SERCA associated with reduced SERCA activity and impaired calcium-related myocyte function. Myocyte-specific overexpression of catalase prevented SERCA OPTM and rescued SERCA activity and isolated myocyte function. Thus, myocyte contractile dysfunction in G␣q-induced cardiomyopathy is mediated, at least in part, by OPTM of SERCA. More broadly, these observations suggest that protein OPTM may contribute to the pathophysiology of myocardial dysfunction in heart failure and other conditions associated with increased myocardial reactive oxygen species and may provide a novel therapeutic target. Myocyte isolation. Myocytes were isolated as we have described previously 4 . Briefly, mice were heparinized and anesthesized with pentobarbital (50mg/kg), hearts were rapidly excised, cannulated and perfused with Ca -free Tyrode (3 min) followed by a solution containing collagenases B and D (Roche) and protease XIV (Sigma) until digestion was complete. Tissue was dissociated using forceps and filtered through a 250µm filter. Myocytes were exposed to solutions of increasing Ca 2+ concentration, and plated in culture chambers (Cell MicroControls, Norfolk, VA) for contractility studies.
Myocyte contraction and calcium transients. Myocyte contraction and intracellular calcium transients were measured as we have described previously 4 . Briefly, freshly isolated myocytes were loaded with 0.5µM Fura2-AM (Invitrogen) diluted in 1.2mM Ca2+ tyrode buffer containing 500µM probenecid for 15min at 37°C. After rinsing, cells were paced at 5Hz at 37°C for 3 min. Myocyte shortening was measured using a video-based edge-detection system SERCA activity. SERCA2 activity was measured using calcium-stimulated, thapsigargininhibitable calcium 45 uptake in an SR membrane preparation, by a modification of published methods 7;8 , as we have described 9 . LV tissues were homogenized on ice in Tris-sucrose WT).
